Discovery of novel nonpeptide tricyclic inhibitors of ras farnesyl protein transferase
摘要:
A comprehensive structure-activity relationship (SAR) study of novel tricyclic amides has been undertaken. The discovery of compounds that are potent FPT inhibitors in the nanomolar range has been achieved. These compounds are nonpeptidic and do not contain sulfhydryl groups. They selectively inhibit farnesyl protein transferase (FPT) and not geranylgeranyl protein transferase-1 (GGPT-1). They also inhibit H-Ras processing in Cos monkey kidney cells. Copyright (C) 1997 Elsevier Science Ltd.
Methods are provided of treating synucleinopathies, such as Parkinson's Disease, Diffuse Lewy Body Disease and Multiple System Atrophy, comprising administering to a synucleinopathic subject a farnesyl transferase inhibitor compound.
Discovery of novel nonpeptide tricyclic inhibitors of ras farnesyl protein transferase
作者:F. George Njoroge、Ronald J. Doll、Bancha Vibulbhan、Carmen S. Alvarez、W. Robert Bishop、Joanne Petrin、Paul Kirschmeier、Nicholas I. Carruthers、Jesse K. Wong、Margaret M. Albanese、John J. Piwinski、Joseph Catino、V. Girijavallabhan、Ashit K. Ganguly
DOI:10.1016/s0968-0896(96)00206-4
日期:1997.1
A comprehensive structure-activity relationship (SAR) study of novel tricyclic amides has been undertaken. The discovery of compounds that are potent FPT inhibitors in the nanomolar range has been achieved. These compounds are nonpeptidic and do not contain sulfhydryl groups. They selectively inhibit farnesyl protein transferase (FPT) and not geranylgeranyl protein transferase-1 (GGPT-1). They also inhibit H-Ras processing in Cos monkey kidney cells. Copyright (C) 1997 Elsevier Science Ltd.